CG
biopharma_cg
Here's a thread regarding investor expectations for $BLU's upcoming phase 2 data. I don't believe that the BLU mgmt and analyst articulated expectations are what investors are ACTUALLY hoping for.
Read more
$MYOV This is extremely strong data. If I were on $ABBV's Orilissa brand team, I would be pretty worried about right now. Let's look at how the data stacks up.
Read more